| Endocrine and other factor-regulated calcium reabsorpti... |
1.84 |
1.19e-1 |
49/53 (92.45%) |
PRKCB;FXYD2;KLK2;...
|
| GABAergic synapse |
1.80 |
8.09e-2 |
76/89 (85.39%) |
PRKCB;GNG12;GABBR1;...
|
| Morphine addiction |
1.67 |
2.34e-1 |
80/91 (87.91%) |
PRKCB;GNG12;GABBR1;...
|
| Allograft rejection |
1.59 |
3.75e-1 |
32/38 (84.21%) |
CD40;HLA-DOB;HLA-DRB1;...
|
| Sulfur relay system |
1.48 |
4.10e-1 |
5/8 (62.5%) |
MPST;NFS1;TST
|
| Oocyte meiosis |
1.47 |
3.76e-1 |
90/129 (69.77%) |
SMC1A;PPP2R5A;STAG3;...
|
| Hematopoietic cell lineage |
1.47 |
3.49e-1 |
90/99 (90.91%) |
CD55;ITGA6;CD34;...
|
| Nicotine addiction |
1.46 |
3.58e-1 |
32/40 (80%) |
SLC17A7;GABRA2;GABRP;...
|
| Cell cycle |
1.45 |
3.48e-1 |
110/124 (88.71%) |
SMC1A;CCNB2;BUB1B;...
|
| Ribosome biogenesis in eukaryotes |
1.45 |
3.24e-1 |
52/108 (48.15%) |
NOL6;NOP10;IMP3;...
|
| Bacterial invasion of epithelial cells |
1.44 |
3.15e-1 |
59/77 (76.62%) |
CAV2;CAV1;PIK3CA;...
|
| RNA polymerase |
1.44 |
2.96e-1 |
23/31 (74.19%) |
POLR1C;POLR1D;POLR2C;...
|
| Intestinal immune network for IgA production |
1.44 |
2.93e-1 |
38/48 (79.17%) |
CD40;HLA-DOB;CXCR4;...
|
| Aldosterone-regulated sodium reabsorption |
1.44 |
2.78e-1 |
34/37 (91.89%) |
SGK1;PRKCB;IRS1;...
|
| Melanogenesis |
1.42 |
2.99e-1 |
74/101 (73.27%) |
WNT5A;PRKCB;LEF1;...
|
| Drug metabolism |
1.41 |
2.85e-1 |
78/151 (51.66%) |
DPYD;GSTP1;IMPDH2;...
|
| Wnt signaling pathway |
1.41 |
2.95e-1 |
124/166 (74.7%) |
WNT5A;NFATC3;PRKCB;...
|
| Bile secretion |
1.40 |
2.86e-1 |
68/90 (75.56%) |
SLCO1B3;FXYD2;KCNN2;...
|
| Metabolism of xenobiotics by cytochrome P450 |
1.40 |
2.78e-1 |
49/77 (63.64%) |
GSTP1;CYP1B1;CYP1A2;...
|
| Transcriptional misregulation in cancer |
1.39 |
3.00e-1 |
158/192 (82.29%) |
TSPAN7;HPGD;CD40;...
|
| Ubiquitin mediated proteolysis |
1.39 |
2.91e-1 |
87/140 (62.14%) |
SKP2;STUB1;CUL3;...
|
| Serotonergic synapse |
1.37 |
3.07e-1 |
97/114 (85.09%) |
PRKCB;GNG12;CYP2C18;...
|
| Primary bile acid biosynthesis |
1.37 |
3.06e-1 |
15/17 (88.24%) |
AKR1C4;BAAT;AKR1D1;...
|
| Proteoglycans in cancer |
1.37 |
2.97e-1 |
172/205 (83.9%) |
WNT5A;LUM;CAV2;...
|
| Human T-cell leukemia virus 1 infection |
1.33 |
3.80e-1 |
197/219 (89.95%) |
NFATC3;CCNB2;BUB1B;...
|
| Caffeine metabolism |
1.32 |
3.70e-1 |
5/6 (83.33%) |
CYP1A2;CYP2A6
|
| Type II diabetes mellitus |
1.32 |
3.65e-1 |
42/46 (91.3%) |
IRS2;IRS1;PIK3CA;...
|
| Adipocytokine signaling pathway |
1.32 |
3.61e-1 |
64/69 (92.75%) |
IRS2;IRS1;NPY;...
|
| VEGF signaling pathway |
1.30 |
3.86e-1 |
50/59 (84.75%) |
PRKCB;PIK3CA;SRC;...
|
| Insulin secretion |
1.28 |
4.24e-1 |
75/86 (87.21%) |
PRKCB;FXYD2;KCNN2;...
|
| Lysosome |
-1.22 |
5.09e-1 |
115/128 (89.84%) |
CTSC;NAGPA;HYAL3;...
|
| Insulin resistance |
-1.22 |
5.08e-1 |
96/108 (88.89%) |
NR1H2;RPS6KB2;CREB1;...
|
| AGE-RAGE signaling pathway in diabetic complications |
-1.22 |
5.09e-1 |
97/100 (97%) |
SMAD3;COL4A1;IL1A;...
|
| Mucin type O-glycan biosynthesis |
-1.23 |
5.16e-1 |
20/36 (55.56%) |
ST3GAL1;ST3GAL2;GALNT8;...
|
| Phagosome |
-1.23 |
5.09e-1 |
118/152 (77.63%) |
MRC2;FCGR2A;ATP6AP1;...
|
| TGF-beta signaling pathway |
-1.23 |
5.08e-1 |
81/94 (86.17%) |
PPP2R1A;TGIF2;BMPR2;...
|
| NOD-like receptor signaling pathway |
-1.24 |
5.03e-1 |
145/181 (80.11%) |
IRAK4;GBP2;IFNAR1;...
|
| Human papillomavirus infection |
-1.24 |
5.13e-1 |
284/331 (85.8%) |
TSC2;COL6A2;TLR3;...
|
| Necroptosis |
-1.24 |
5.17e-1 |
113/159 (71.07%) |
IFNAR1;IFNGR2;SHARPIN;...
|
| ECM-receptor interaction |
-1.25 |
5.24e-1 |
80/88 (90.91%) |
COL6A2;ITGAV;COL9A1;...
|
| One carbon pool by folate |
-1.26 |
5.17e-1 |
15/20 (75%) |
ALDH1L1;DHFR;MTHFD2;...
|
| Glutathione metabolism |
-1.27 |
4.98e-1 |
43/57 (75.44%) |
GSTT1;PRDX6;GCLM;...
|
| Thiamine metabolism |
-1.27 |
4.89e-1 |
12/15 (80%) |
AK1;AK4
|
| Steroid biosynthesis |
-1.28 |
4.93e-1 |
19/20 (95%) |
CYP2R1;FDFT1;SOAT1;...
|
| Tuberculosis |
-1.28 |
5.02e-1 |
159/180 (88.33%) |
IL10RB;MRC2;BID;...
|
| Cytokine-cytokine receptor interaction |
-1.28 |
5.15e-1 |
246/295 (83.39%) |
BMP7;IL1RL1;CCL5;...
|
| Fatty acid degradation |
-1.29 |
5.24e-1 |
40/43 (93.02%) |
ACADL;ECHS1;ADH1C;...
|
| Diabetic cardiomyopathy |
-1.31 |
5.00e-1 |
162/203 (79.8%) |
TGFBR2;COX5B;SMAD2;...
|
| Malaria |
-1.32 |
5.07e-1 |
44/50 (88%) |
THBS2;ITGAL;ACKR1;...
|
| Renin-angiotensin system |
-1.32 |
5.24e-1 |
20/23 (86.96%) |
LNPEP;ANPEP;ACE2;...
|
| Circadian rhythm |
-1.33 |
5.16e-1 |
26/31 (83.87%) |
CSNK1E;BHLHE40;PRKAA1;...
|
| TNF signaling pathway |
-1.41 |
4.93e-1 |
103/112 (91.96%) |
NOD2;PIK3R3;CX3CL1;...
|
| Ascorbate and aldarate metabolism |
-1.41 |
5.23e-1 |
15/30 (50%) |
UGT2A3;ALDH7A1;ALDH3A2;...
|
| Neomycin, kanamycin and gentamicin biosynthesis |
-1.52 |
3.90e-1 |
5/5 (100%) |
HK1;HK3;HK2
|
| Legionellosis |
-1.53 |
4.24e-1 |
51/57 (89.47%) |
HSF1;RAB1B;IL18;...
|
| Mineral absorption |
-1.58 |
3.29e-1 |
48/60 (80%) |
MT1E;SLC39A4;ATP1A2;...
|
| PPAR signaling pathway |
-1.59 |
3.91e-1 |
66/74 (89.19%) |
PLTP;ACAA1;CPT1A;...
|
| Starch and sucrose metabolism |
-1.62 |
3.87e-1 |
25/36 (69.44%) |
HK1;PYGM;GAA;...
|
| Ferroptosis |
-1.72 |
1.87e-1 |
36/41 (87.8%) |
SLC3A2;CP;TP53;...
|
| Amino sugar and nucleotide sugar metabolism |
-1.72 |
3.65e-1 |
38/48 (79.17%) |
NPL;HEXB;HK1;...
|
